OMNIAB, INC. Depreciation
OMNIAB, INC. (OABI) reported Depreciation of $600.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-06
- OMNIAB, INC. depreciation for the quarter ending 2026-06-30 was $600.00K, a 25.00% decline year-over-year.
- OMNIAB, INC. depreciation for the quarter ending 2026-03-31 was $606.00K, a 37.27% decline year-over-year.
- OMNIAB, INC. depreciation for the quarter ending 2025-12-31 was $3.90M, a 290.00% increase year-over-year.
- OMNIAB, INC. depreciation for the quarter ending 2025-09-30 was $900.00K, a 10.00% decline year-over-year.
- OMNIAB, INC. depreciation for fiscal 2025 was $6.60M, a 60.98% increase from fiscal 2024.
- OMNIAB, INC. depreciation for fiscal 2024 was $4.10M, a 2.50% increase from fiscal 2023.
- OMNIAB, INC. depreciation for fiscal 2023 was $4.00M, a 25.00% increase from fiscal 2022.
- OMNIAB, INC. depreciation for fiscal 2022 was $3.20M, a 60.00% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 3 month as first filed | Depreciation 6 month | Depreciation 6 month as first filed | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $600.00K 10-Q · filed 2026-08-06 | $1.18M 10-Q · filed 2026-08-06 | $5.11M derived: sum of 3 quarters · filed 2026-08-06 | $6.01M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | $606.00K 10-Q · filed 2026-05-07 | $4.51M derived: sum of 2 quarters · filed 2026-05-07 | $5.41M derived: sum of 3 quarters · filed 2026-05-07 | $6.21M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-12-31 | $3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $4.80M derived: sum of 2 quarters · filed 2026-03-04 | $5.60M derived: sum of 3 quarters · filed 2026-08-06 | $6.60M 10-K · filed 2026-03-04 | ||
| 2025-09-30 | $900.00K 10-Q · filed 2025-11-04 | $1.70M derived: sum of 2 quarters · filed 2026-08-06 | $2.70M 10-Q · filed 2025-11-04 | $3.67M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | $800.00K 10-Q · filed 2026-08-06 | $1.83M 10-Q · filed 2026-08-06 | $1.80M 10-Q · filed 2025-08-06 | $2.77M derived: sum of 3 quarters · filed 2026-08-06 | $3.77M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $966.00K 10-Q · filed 2026-05-07 | $1.00M 10-Q · filed 2025-05-08 | $1.97M derived: sum of 2 quarters · filed 2026-05-07 | $2.97M derived: sum of 3 quarters · filed 2026-05-07 | $4.07M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $2.00M derived: sum of 2 quarters · filed 2026-03-04 | $3.10M derived: sum of 3 quarters · filed 2026-03-04 | $4.10M 10-K · filed 2026-03-04 | ||
| 2024-09-30 | $1.00M 10-Q · filed 2025-11-04 | $2.10M derived: sum of 2 quarters · filed 2025-11-04 | $3.10M 10-Q · filed 2025-11-04 | $4.10M derived: sum of 4 quarters · filed 2025-11-04 | ||
| 2024-06-30 | $1.10M 10-Q · filed 2025-08-06 | $2.10M 10-Q · filed 2025-08-06 | $3.10M derived: sum of 3 quarters · filed 2025-08-06 | $4.10M derived: sum of 4 quarters · filed 2025-08-06 | ||
| 2024-03-31 | $1.00M 10-Q · filed 2025-05-08 | $2.00M derived: sum of 2 quarters · filed 2025-05-08 | $3.00M derived: sum of 3 quarters · filed 2025-05-08 | $4.00M derived: sum of 4 quarters · filed 2025-05-08 | ||
| 2023-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $2.00M derived: sum of 2 quarters · filed 2025-03-18 | $3.00M derived: sum of 3 quarters · filed 2025-03-18 | $4.00M 10-K · filed 2025-03-18 | ||
| 2023-09-30 | $1.00M 10-Q · filed 2024-11-12 | $2.00M derived: sum of 2 quarters · filed 2024-11-12 | $3.00M 10-Q · filed 2024-11-12 | $4.30M derived: sum of 4 quarters · filed 2024-11-12 | ||
| 2023-06-30 | $1.00M 10-Q · filed 2024-08-08 | $2.00M 10-Q · filed 2024-08-08 | $3.30M derived: sum of 3 quarters · filed 2024-08-08 | $4.00M derived: sum of 4 quarters · filed 2024-08-08 | ||
| 2023-03-31 | $1.00M 10-Q · filed 2024-05-09 | $2.30M derived: sum of 2 quarters · filed 2024-05-09 | $3.00M derived: sum of 3 quarters · filed 2024-05-09 | $3.60M derived: sum of 4 quarters · filed 2024-05-09 | ||
| 2022-12-31 | $1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $2.00M derived: sum of 2 quarters · filed 2024-03-25 | $2.60M derived: sum of 3 quarters · filed 2024-03-25 | $3.20M 10-K · filed 2024-03-25 | ||
| 2022-09-30 | $700.00K 10-Q · filed 2023-11-09 | $1.30M derived: sum of 2 quarters · filed 2023-11-09 | $1.90M 10-Q · filed 2023-11-09 | |||
| 2022-06-30 | $600.00K 10-Q · filed 2023-08-10 | $1.20M 10-Q · filed 2023-08-10 | ||||
| 2022-03-31 | $600.00K 10-Q · filed 2023-05-11 | |||||
| 2021-12-31 | $2.00M 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |